| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/28/2011 | US20110184041 PTHrP, ITS ISOFORMS AND ANTAGONIST THERETO IN THE DIAGNOSIS AND TREATMENT OF DISEASE |
| 07/28/2011 | US20110184039 Pharmaceutical formulation |
| 07/28/2011 | US20110184038 Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 07/28/2011 | US20110184037 Methods for treating an intervertebral disc using local analgesics |
| 07/28/2011 | US20110184036 Formulations of bendamustine |
| 07/28/2011 | US20110184035 Methods of treating degenerative diseases/injuries |
| 07/28/2011 | US20110184034 Severe sepsis preventive therapeutic agent |
| 07/28/2011 | US20110184033 Selective Ligands for the Dopamine 3 (D3) Receptor and Methods of using the Same |
| 07/28/2011 | US20110184032 Novel Phenylamino Isonicotinamide Compounds |
| 07/28/2011 | US20110184031 G-Protein-Conjugated Receptor Agonist |
| 07/28/2011 | US20110184030 Pharmaceutically acceptable salt and polymorphic forms of flupirtine maleate |
| 07/28/2011 | US20110184029 Pyridone derivatives as non-nucleoside reverse transcriptase inhibitors |
| 07/28/2011 | US20110184028 Derivatives of pyridoxine for inhibiting hiv integrase |
| 07/28/2011 | US20110184027 Tissue selective stearoyl-coa desaturase 1 inhibitors and cell based screening assay for their identification |
| 07/28/2011 | US20110184026 C4-substituted alpha-keto oxazoles |
| 07/28/2011 | US20110184025 Methods and Compositions Using Immunomodulatory Compounds for the Treatment and Management of Spirochete and Other Obligate Intracellular Bacterial Diseases |
| 07/28/2011 | US20110184024 Pharmaceutical Composition Containing Esomeprazole |
| 07/28/2011 | US20110184023 The salts of n-[4-(1-cyanocyclopentyl)phenyl]-2-(4-pyridylmethyl)amino-3-pyridinecarboxamide |
| 07/28/2011 | US20110184022 Organic Compounds |
| 07/28/2011 | US20110184021 2-Acylaminopropoanol-Type Glucosylceramide Synthase Inhibitors |
| 07/28/2011 | US20110184020 Vanilloid Receptor Ligands, Pharmaceutical Compositions Containing Them, Process For Making Them, and Use Thereof For Treating Pain and Other Conditions |
| 07/28/2011 | US20110184019 Long chain N-Alkyl compounds and oxa-derivatives thereof |
| 07/28/2011 | US20110184018 Method for treating peripheral neuropathic pain |
| 07/28/2011 | US20110184017 Stable aqueous solution composition containing sulfonamide compound |
| 07/28/2011 | US20110184016 Prevention and treatment of itch with cysteine protease inhibition |
| 07/28/2011 | US20110184015 Novel derivatives of pyrroloindole which are inhibitors of hsp90, compositions containing same, and use thereof |
| 07/28/2011 | US20110184014 New compounds |
| 07/28/2011 | US20110184013 Imidazo[1,2-a]Pyridine Compounds As Receptor Tyrosine Kinase Inhibitors |
| 07/28/2011 | US20110184012 Methods and compositions for alleviating stuttering |
| 07/28/2011 | US20110184011 Compounds |
| 07/28/2011 | US20110184010 Method of treating mantle cell lymphoma |
| 07/28/2011 | US20110184009 Camptothecin derivatives as chemoradiosensitizing agents |
| 07/28/2011 | US20110184008 Crystalline forms of an 8-azabicyclo[3.2.1]octane compound |
| 07/28/2011 | US20110184007 Pharmaceutical compositions configured to deter dosage form splitting |
| 07/28/2011 | US20110184006 Method and composition for thermally stabilizing vitamin c within nano layers of montmorillonite clay |
| 07/28/2011 | US20110184005 Predictive marker for egfr inhibitor treatment |
| 07/28/2011 | US20110184004 Predictive marker for egfr inhibitor treatment |
| 07/28/2011 | US20110184003 Compounds and methods for the treatment of viral infection |
| 07/28/2011 | US20110184002 Method of treating hepatic disease using a2b adenosine receptor antagonists |
| 07/28/2011 | US20110184001 Inhibitors of bruton's tyrosine kinase |
| 07/28/2011 | US20110184000 1-heterocyclyl-1,5-dihydro-pyrazolo[3,4-d] pyrimidin-4-one derivates and their use as pde9a modulators |
| 07/28/2011 | US20110183999 Novel polymorphic forms of methyl carbamate |
| 07/28/2011 | US20110183998 Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
| 07/28/2011 | US20110183997 Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 07/28/2011 | US20110183996 The 1-butyl-2-hydroxyaralkyl piperazine derivatives and the uses as anti-depression medicine thereof |
| 07/28/2011 | US20110183995 Eltoprazine for suppression of l-dopa induced dyskinesias |
| 07/28/2011 | US20110183994 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
| 07/28/2011 | US20110183993 Cycloalkane derivative |
| 07/28/2011 | US20110183992 Therapeutic agent for migraine |
| 07/28/2011 | US20110183991 5ht7 receptor ligands and compositions comprising the same |
| 07/28/2011 | US20110183990 Method of treating atrial fibrillation |
| 07/28/2011 | US20110183989 Saturated bicyclic heterocyclic derivatives as smo antagonists |
| 07/28/2011 | US20110183988 Compounds and methods for kinase modulation, and indications therefor |
| 07/28/2011 | US20110183987 Stereoselective Synthesis of Bicyclic Heterocycles |
| 07/28/2011 | US20110183986 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/28/2011 | US20110183985 Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors |
| 07/28/2011 | US20110183984 Small molecule inhibitors of lck sh2 domain binding |
| 07/28/2011 | US20110183983 Heterocyclic compound as protein kinase inhibitor |
| 07/28/2011 | US20110183982 Phenoxy acetic acids as ppar delta activators |
| 07/28/2011 | US20110183981 Heterocyclic inhibitors of mek and methods of use thereof |
| 07/28/2011 | US20110183980 O-benzyl nicotinamide analogs as mglur5 positive allosteric modulators |
| 07/28/2011 | US20110183979 Nitrogen-containing heteroaryl derivatives |
| 07/28/2011 | US20110183977 Benzene, pyridine, and pyridazine derivatives |
| 07/28/2011 | US20110183976 5- and 6-membered heterocyclic compounds |
| 07/28/2011 | US20110183975 Novel 6-azaindole aminopyrimidine derivatives having nik inhibitory activity |
| 07/28/2011 | US20110183974 1,2,4-oxadiazole substituted piperidine and piperazine derivatives as smo antagonists |
| 07/28/2011 | US20110183973 Novel Compounds |
| 07/28/2011 | US20110183972 Aromatic ring fused triazine derivatives and uses thereof |
| 07/28/2011 | US20110183971 3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 07/28/2011 | US20110183969 Antifungal combination therapy |
| 07/28/2011 | US20110183968 Antifungal compounds containing benzothiazinone, benzoxazinone or benzoxazolinone and process thereof |
| 07/28/2011 | US20110183967 Benzoxazole compounds and methods of use |
| 07/28/2011 | US20110183966 Aminopyridine kinase inhibitors |
| 07/28/2011 | US20110183965 6-aminoisoquinoline compounds |
| 07/28/2011 | US20110183964 Hydroxamate-based inhibitors of deacetylases b |
| 07/28/2011 | US20110183963 Amino Acid Conjugates of Quetiapine, Process for Making and Using the Same |
| 07/28/2011 | US20110183962 Smoothened antagonism for the treatment of hedgehog pathway-related disorders |
| 07/28/2011 | US20110183961 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 07/28/2011 | US20110183960 Thiophene-2-carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 07/28/2011 | US20110183959 P38 kinase inhibiting agents |
| 07/28/2011 | US20110183958 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 07/28/2011 | US20110183957 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| 07/28/2011 | US20110183956 Process for the synthesis of ezetimibe and intermediates useful therefor |
| 07/28/2011 | US20110183955 2-Aminocarbonyl Substituted Piperazine or Diaza-Cyclic Compounds as Apoptosis Protein Inhibitors (Iap) Modulators |
| 07/28/2011 | US20110183954 Tricyclic 2,4-diamino-l,3,5-triazine derivatives useful for the treatment of cancer and myeloproliferative disorders |
| 07/28/2011 | US20110183953 Selective heterocyclic sphingosine 1 phosphate receptor modulators |
| 07/28/2011 | US20110183952 New chemical compounds |
| 07/28/2011 | US20110183951 Copper (1) Complex |
| 07/28/2011 | US20110183950 Treatment of vaginal atrophy in women with tumor pathology risk |
| 07/28/2011 | US20110183949 Use of Fulvestrant in the Treatment of Resistant Breast Cancer |
| 07/28/2011 | US20110183948 Treatment of fibrotic conditions using hedgehog inhibitors |
| 07/28/2011 | US20110183947 Alpha-keto heterocycles as faah inhibitors |
| 07/28/2011 | US20110183946 Complexes Comprising alpha2-Adrenergic Receptor Agonists and Methods of Providing Neuroprotection or Treating or Inhibiting Progression of Glaucoma |
| 07/28/2011 | US20110183945 Long acting curcumin derivative, preparation method and pharmaceutical use thereof |
| 07/28/2011 | US20110183944 SUSTAINED-RELEASE NSAID/HMG CoA REDUCTASE INHIBITOR COMPOSITIONS |
| 07/28/2011 | US20110183943 Concurrent therapy regime/regimen for the treatment of acne related diseases |
| 07/28/2011 | US20110183942 Methods and Compositions for Treating Alzheimer's Disease |
| 07/28/2011 | US20110183940 Chemical compounds |
| 07/28/2011 | US20110183939 Novel pyrolinone derivative and pharmaceutical composition comprising the same |
| 07/28/2011 | US20110183938 1,7-diazacarbazoles and methods of use |